FI942160L - Substituoituja mono- ja bipyridyylimetyylipyridoneja - Google Patents

Substituoituja mono- ja bipyridyylimetyylipyridoneja Download PDF

Info

Publication number
FI942160L
FI942160L FI942160A FI942160A FI942160L FI 942160 L FI942160 L FI 942160L FI 942160 A FI942160 A FI 942160A FI 942160 A FI942160 A FI 942160A FI 942160 L FI942160 L FI 942160L
Authority
FI
Finland
Prior art keywords
bipyridylmethylpyridones
substituted mono
mono
substituted
Prior art date
Application number
FI942160A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI942160A7 (fi
FI942160A0 (fi
Inventor
Peter Fey
Walter Huebsch
Juergen Dressel
Rudolf Hanko
Thomas Kraemer
Ulrich Mueller
Matthias Mueller-Gliemann
Martin Beuck
Hilmar Bischoff
Stefan Wohlfeil
Dirk Denzer
Stanislav Kazda
Johannes-Peter Stasch
Andreas Knorr
Siegfried Zaiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI942160A0 publication Critical patent/FI942160A0/fi
Publication of FI942160A7 publication Critical patent/FI942160A7/fi
Publication of FI942160L publication Critical patent/FI942160L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI942160A 1993-05-13 1994-05-10 Substituoituja mono- ja bipyridyylimetyylipyridoneja FI942160L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4316077A DE4316077A1 (de) 1993-05-13 1993-05-13 Substituierte Mono- und Bihydridylmethylpyridone

Publications (3)

Publication Number Publication Date
FI942160A0 FI942160A0 (fi) 1994-05-10
FI942160A7 FI942160A7 (fi) 1994-11-14
FI942160L true FI942160L (fi) 1994-11-14

Family

ID=6488035

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942160A FI942160L (fi) 1993-05-13 1994-05-10 Substituoituja mono- ja bipyridyylimetyylipyridoneja

Country Status (21)

Country Link
US (1) US5407948A (esLanguage)
EP (1) EP0624583B1 (esLanguage)
JP (1) JPH06329669A (esLanguage)
CN (1) CN1102648A (esLanguage)
AT (1) ATE155782T1 (esLanguage)
AU (1) AU672679B2 (esLanguage)
CA (1) CA2123243A1 (esLanguage)
CZ (1) CZ117294A3 (esLanguage)
DE (2) DE4316077A1 (esLanguage)
DK (1) DK0624583T3 (esLanguage)
ES (1) ES2105408T3 (esLanguage)
FI (1) FI942160L (esLanguage)
GR (1) GR3024465T3 (esLanguage)
HU (1) HUT70485A (esLanguage)
IL (1) IL109604A0 (esLanguage)
NO (1) NO941770L (esLanguage)
NZ (1) NZ260490A (esLanguage)
PH (1) PH30908A (esLanguage)
SK (1) SK55694A3 (esLanguage)
TW (1) TW245718B (esLanguage)
ZA (1) ZA943246B (esLanguage)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0802192A1 (de) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19619950A1 (de) 1996-04-17 1997-10-23 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
ATE274510T1 (de) 1998-06-19 2004-09-15 Chiron Corp Glycogen synthase kinase 3 inhibitoren
CA2469435A1 (en) 2001-12-21 2003-07-24 X-Ceptor Therapeutics, Inc. Modulators of lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
EP1490064B1 (en) * 2002-02-14 2009-11-18 Pharmacia Corporation Substituted pyridinones as modulators of p38 map kinase
US6930117B2 (en) * 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones
US7786120B2 (en) * 2005-08-29 2010-08-31 Vertex Pharmaceuticals Incorporated Pyridones useful as inhibitors of kinases
US7691885B2 (en) * 2005-08-29 2010-04-06 Vertex Pharmaceuticals Incorporated Pyridones useful as inhibitors of kinases
CA2620352A1 (en) 2005-08-29 2007-03-08 Vertex Pharmaceuticals Incorporated 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
WO2009033703A1 (en) * 2007-09-14 2009-03-19 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
BRPI0816767B8 (pt) 2007-09-14 2021-05-25 Addex Pharmaceuticals Sa composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos
ES2365966T3 (es) 2007-09-14 2011-10-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-disustituidas.
ES2637794T3 (es) * 2007-11-14 2017-10-17 Janssen Pharmaceuticals, Inc. Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
BRPI0920354A2 (pt) 2008-10-16 2017-06-27 Addex Pharmaceuticals Sa derivados de indol e benzomorfolina como moduladores de receptores de glutamato metabotrópicos
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
BRPI1010831A2 (pt) 2009-05-12 2016-04-05 Addex Pharmaceuticals Sa derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
SG176021A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
KR20140095105A (ko) * 2009-11-06 2014-07-31 에르피오 세러퓨틱스 인코포레이티드 대장염 치료용 조성물 및 방법
PT2649069E (pt) 2010-11-08 2015-11-20 Janssen Pharmaceuticals Inc Derivados de 1,2,4-triazolo[4,3-a]piridina e sua utilização como moduladores alostéricos positivos de recetores mglur2
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
HUE045610T2 (hu) 2014-01-21 2020-01-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk
PH12021552653A1 (en) 2014-01-21 2023-07-17 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
EP4288430A1 (en) 2021-02-02 2023-12-13 Liminal Biosciences Limited Gpr84 antagonists and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100917A0 (en) * 1991-02-16 1992-11-15 Fisons Plc Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5128327A (en) * 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
US5155117A (en) * 1991-04-12 1992-10-13 G. D. Searle & Co. 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
DE4129340A1 (de) * 1991-09-04 1993-03-11 Merck Patent Gmbh 1,2-dihydro-2-oxopyridine
US5332750A (en) * 1991-09-04 1994-07-26 Merck Patent Gesellschaft Mit Beschrankter Haftung 1,2-dihydro-2-oxopyridines
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
PH30908A (en) 1997-12-23
EP0624583B1 (de) 1997-07-23
HUT70485A (en) 1995-10-30
NO941770L (no) 1994-11-14
TW245718B (esLanguage) 1995-04-21
CZ117294A3 (en) 1994-11-16
DK0624583T3 (da) 1998-03-02
SK55694A3 (en) 1995-02-08
JPH06329669A (ja) 1994-11-29
DE4316077A1 (de) 1994-11-17
NO941770D0 (no) 1994-05-11
ATE155782T1 (de) 1997-08-15
US5407948A (en) 1995-04-18
DE59403427D1 (de) 1997-08-28
FI942160A7 (fi) 1994-11-14
ES2105408T3 (es) 1997-10-16
HU9401417D0 (en) 1994-08-29
ZA943246B (en) 1995-01-18
AU6056194A (en) 1994-11-17
IL109604A0 (en) 1994-08-26
AU672679B2 (en) 1996-10-10
NZ260490A (en) 1995-12-21
CN1102648A (zh) 1995-05-17
GR3024465T3 (en) 1997-11-28
EP0624583A1 (de) 1994-11-17
CA2123243A1 (en) 1994-11-14
FI942160A0 (fi) 1994-05-10

Similar Documents

Publication Publication Date Title
FI942160A7 (fi) Substituoituja mono- ja bipyridyylimetyylipyridoneja
FI945690L (fi) Substituoitu N-piperidino-3-pyratsolikarboksamidi
DE69407573D1 (de) Fluorsiloxanhydrogele
NO944469L (no) Imidazopyridaziner
FI940154L (fi) Substituoidut dialkyylitioeetterit
FI954326A0 (fi) Varjoaineisiin liittyviä parannuksia
ATA146094A (de) Windsichter
DE59403503D1 (de) Substituierte 1-Aryltriazolinone
FI940011A7 (fi) Mono- ja bis-alkyyliaminoantrasykliinit
FI956304L (fi) Substituoidut aryltioalkyylitiopyridiinit
ATA212793A (de) Sportschuh
ATA179094A (de) Kettenschloss
ATA194593A (de) Sportschuh
FI935534A7 (fi) Teline
FI962301L (fi) Substituoidut aminoalkyyliaminopyridiinit
BR9405830A (pt) Oxazois substituidos
DE69433472D1 (de) Recognin vakzine
FI933875A0 (fi) Viistoneulataulunkannatin
DE59410298D1 (de) Hefeerntetank
ATE144907T1 (de) Rollbrett
FI1195U1 (fi) Naetfaner
FI946U1 (fi) Blompelare
BR9301237A (pt) Axiostato
BR9303364A (pt) Infratometro
BR7302251U (pt) Embalagem-produto-inviolável